SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-21-000030
Filing Date
2021-08-12
Accepted
2021-08-12 16:17:17
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20210630.htm   iXBRL 10-Q 1104220
2 EX-10.1 sls-20160630ex101.htm EX-10.1 61232
3 EX-31.1 sls-20210630ex311.htm EX-31.1 8301
4 EX-31.2 sls-20210630ex312.htm EX-31.2 8305
5 EX-32.1 sls-20210630ex321.htm EX-32.1 6713
11 sls-20210630_g1.jpg GRAPHIC 30719
  Complete submission text file 0001390478-21-000030.txt   5513182

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sls-20210630.xsd EX-101.SCH 44110
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sls-20210630_cal.xml EX-101.CAL 53259
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sls-20210630_def.xml EX-101.DEF 164207
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sls-20210630_lab.xml EX-101.LAB 491914
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sls-20210630_pre.xml EX-101.PRE 323228
12 EXTRACTED XBRL INSTANCE DOCUMENT sls-20210630_htm.xml XML 869234
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 211167810
SIC: 2834 Pharmaceutical Preparations